141 related articles for article (PubMed ID: 22892083)
41. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.
Montero Girard G; Vanzulli SI; Cerliani JP; Bottino MC; Bolado J; Vela J; Becu-Villalobos D; Benavides F; Gutkind S; Patel V; Molinolo A; Lanari C
Breast Cancer Res; 2007; 9(2):R22. PubMed ID: 17341305
[TBL] [Abstract][Full Text] [Related]
42. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
43. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Dran G; Luthy IA; Molinolo AA; Montecchia F; Charreau EH; Pasqualini CD; Lanari C
Breast Cancer Res Treat; 1995 Aug; 35(2):173-86. PubMed ID: 7647339
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
Soldati R; Wargon V; Cerliani JP; Giulianelli S; Vanzulli SI; Gorostiaga MA; Bolado J; do Campo P; Molinolo A; Vollmer G; Lanari C
Breast Cancer Res Treat; 2010 Oct; 123(3):709-24. PubMed ID: 20012353
[TBL] [Abstract][Full Text] [Related]
45. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
46. BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
van de Ven M; Liu X; van der Burg E; Klarenbeek S; Alexi X; Zwart W; Dijcks F; Bouwman P; Jonkers J
J Pathol; 2018 Sep; 246(1):41-53. PubMed ID: 29877575
[TBL] [Abstract][Full Text] [Related]
47. The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.
Lanari C; Lamb CA; Fabris VT; Helguero LA; Soldati R; Bottino MC; Giulianelli S; Cerliani JP; Wargon V; Molinolo A
Endocr Relat Cancer; 2009 Jun; 16(2):333-50. PubMed ID: 19190078
[TBL] [Abstract][Full Text] [Related]
48. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.
Ochnik AM; Moore NL; Jankovic-Karasoulos T; Bianco-Miotto T; Ryan NK; Thomas MR; Birrell SN; Butler LM; Tilley WD; Hickey TE
Menopause; 2014 Jan; 21(1):79-88. PubMed ID: 23715406
[TBL] [Abstract][Full Text] [Related]
49. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
Bray JD; Jelinsky S; Ghatge R; Bray JA; Tunkey C; Saraf K; Jacobsen BM; Richer JK; Brown EL; Winneker RC; Horwitz KB; Lyttle CR
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):328-41. PubMed ID: 16157482
[TBL] [Abstract][Full Text] [Related]
50. Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
Díaz Flaqué MC; Galigniana NM; Béguelin W; Vicario R; Proietti CJ; Russo R; Rivas MA; Tkach M; Guzmán P; Roa JC; Maronna E; Pineda V; Muñoz S; Mercogliano M; Charreau EH; Yankilevich P; Schillaci R; Elizalde PV
Breast Cancer Res; 2013 Dec; 15(6):R118. PubMed ID: 24345432
[TBL] [Abstract][Full Text] [Related]
51. G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells.
Ahola TM; Manninen T; Alkio N; Ylikomi T
Endocrinology; 2002 Sep; 143(9):3376-84. PubMed ID: 12193550
[TBL] [Abstract][Full Text] [Related]
52. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
Buchanan G; Birrell SN; Peters AA; Bianco-Miotto T; Ramsay K; Cops EJ; Yang M; Harris JM; Simila HA; Moore NL; Bentel JM; Ricciardelli C; Horsfall DJ; Butler LM; Tilley WD
Cancer Res; 2005 Sep; 65(18):8487-96. PubMed ID: 16166329
[TBL] [Abstract][Full Text] [Related]
53. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
Wu J; Liang Y; Nawaz Z; Hyder SM
Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
[TBL] [Abstract][Full Text] [Related]
54. Estrogen inhibition of MPA-induced mouse mammary tumor transplants.
Kordon E; Lanari C; Molinolo AA; Elizalde PV; Charreau EH; Dosne Pasqualini C
Int J Cancer; 1991 Dec; 49(6):900-5. PubMed ID: 1835715
[TBL] [Abstract][Full Text] [Related]
55. The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2001; 22(5):331-5. PubMed ID: 11766732
[TBL] [Abstract][Full Text] [Related]
56. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz MA; Ozpinar A; Elmaci I
Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
[TBL] [Abstract][Full Text] [Related]
57. Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.
Reyes D; Ballaré C; Castellano G; Soronellas D; Bagó JR; Blanco J; Beato M
Oncogene; 2014 Mar; 33(12):1570-80. PubMed ID: 23604116
[TBL] [Abstract][Full Text] [Related]
58. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines.
Ewing TM; Murphy LJ; Ng ML; Pang GY; Lee CS; Watts CK; Sutherland RL
Int J Cancer; 1989 Oct; 44(4):744-52. PubMed ID: 2793247
[TBL] [Abstract][Full Text] [Related]
59. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.
Sartorius CA; Harvell DM; Shen T; Horwitz KB
Cancer Res; 2005 Nov; 65(21):9779-88. PubMed ID: 16266999
[TBL] [Abstract][Full Text] [Related]
60. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
Giulianelli S; Cerliani JP; Lamb CA; Fabris VT; Bottino MC; Gorostiaga MA; Novaro V; Góngora A; Baldi A; Molinolo A; Lanari C
Int J Cancer; 2008 Dec; 123(11):2518-31. PubMed ID: 18767044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
